Back to results
US 2014/0235577 A1Published application
External skin agent comprising modified clay for preventing inflammation
AssigneesTaisho Pharmaceutical Co., Ltd., Pola Chemical Industries Inc.
InventorsYasuhiro Ohara, Masashi SUZUKI, Norikazu Takano, Shunpei Mitsuyama
Life of this patent
Estimating the term…
Abstract
To provide An external skin agent that prevents onset of atopic skin inflammations and is low irritant to skin, which is characterized by including: 1) clay modified by a compound having a quaternary amino group; and 2) a polymer or copolymer that has a side chain including a structure similar to a biological component.
Claims14
1-15. (canceled)
An external skin agent comprising:
- 1) montmorillonite, hectorite, or kaolinite modified by a compound having a quaternary amino group;
- and
- 2) a polymer or copolymer having a side chain including a structure of a saccharide residue, an amino acid residue, or a phospholipid residue.
Dependencies are inferred from the claim text.